CN104147580A - Moxa for treating hyperostosis - Google Patents

Moxa for treating hyperostosis Download PDF

Info

Publication number
CN104147580A
CN104147580A CN201410437261.XA CN201410437261A CN104147580A CN 104147580 A CN104147580 A CN 104147580A CN 201410437261 A CN201410437261 A CN 201410437261A CN 104147580 A CN104147580 A CN 104147580A
Authority
CN
China
Prior art keywords
parts
moxa roll
hyperosteogeny
folium artemisiae
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410437261.XA
Other languages
Chinese (zh)
Other versions
CN104147580B (en
Inventor
姚荣翠
覃志明
刘金秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guilin baoguhong AI Pharmaceutical Technology Co., Ltd
Original Assignee
GUILIN AIKANG TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUILIN AIKANG TECHNOLOGY Co Ltd filed Critical GUILIN AIKANG TECHNOLOGY Co Ltd
Priority to CN201410437261.XA priority Critical patent/CN104147580B/en
Publication of CN104147580A publication Critical patent/CN104147580A/en
Application granted granted Critical
Publication of CN104147580B publication Critical patent/CN104147580B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a moxa for treating hyperostosis. The moxa is prepared from the following raw materials in parts by weight: 80-95 parts of fiber of common mugwort, 10-20 parts of radix clematidis, 10-15 parts of pyrola, 8-15 parts of tortoise shell, 8-12 parts of peach kernel, 5-10 parts of cibotium barometz, 2-8 parts of rehmannia glutinosa, 2-7 parts of angelica sinensis, and 1-5 parts of dried ginger. Compared with the prior art, the moxa disclosed by the invention is obvious in the effect of treating hyperostosis, free of stimulation to intestines and stomach, mild for the using process, and up to the effective rate of more than 97.5%.

Description

A kind of moxa roll for the treatment of hyperosteogeny
Technical field
The present invention relates to moxa-moxibustion medicine field, particularly a kind of moxa roll for the treatment of hyperosteogeny.
Background technology
Moxibustion treatment is one of elite of Traditional Chinese Medicine, and it has advantages of that many other therapies do not have.In known moxibustion treatment, moxa-moxibustion medicine used is all to adopt natural Folium Artemisiae Argyi, make Folium Artemisiae Argyi, and make certain shape, as be twisted under upper point the moxa cone of circle, the volatile oil that in Folium Artemisiae Argyi, itself contains, in oil, be mainly iodine, also contain 8-Folium eucalypti globueli (Eucalyptus globulus Labill.) essence, α-absinthol, α-phellandrene, β Flos Caryophylli alkene, camphene, Camphora, carvone, trans reed alcohol, IQ terpineol, be placed on certain position or certain acupuncture point of human body human body, burning Folium Artemisiae Argyi, distinctive smell and the ultrared stimulation of sending by Chinese mugwort fire, the specific meridional point of the human body that fire-cures, energy temperature three-way meridian, QI and blood regulating, blood circulation promoting, clinically except for sympotoms caused by cold factors, chronic prolonged illness, and outside the people of oxygen deficiency, long-term moxibustion can also reach the effect of prevent disease and body-building health, to children's and elderly and infirm, moxibustion treatment is more superior compared with its method.
Hyperosteogeny is current a kind of modal joint disease, bony spur pressuring nerve occurs at osteoarthrosis place and cause numb hand and foot pain, bends and stretches walking unfavorable, neck and lumbar pain, Sciatica, headache etc.These are sick many by the Kidney-Yin tool void of Liver and kidney, and muscles and bones mistake is supported and caused distortion, enlargement, long bone thorn; So-called " Kidney-Yin " be " scleroprotein " collagen fiber said on modern medicine and.Or injure joint and cause qi depression to blood stasis to cause distortion in joint by wound, enlargement, long bone thorn.The traditional Chinese medical science thinks to wherein a kind of viewpoint of hyperosteogeny, and hyperosteogeny is qi stagnation and blood stasis type.Joint stiffness, joint stuffiness are called spasm syndrome by the traditional Chinese medical science, and moving difficulty, limb muscle atrophy are called to myopathy, and pain, numbness are called to arthromyodynia.Reason is impaired External Force Acting, and bones and muscles injury is difficult to bear, coagulation of QI-blood, blockage of main and collateral channels, stagnation of QI and blood may bring about pain, and channels hinders that blood is excessive, forms this disease.
At present, the method for the treatment of hyperosteogeny mainly contains Drug therapy, pin cutter and anesthesia needle treatment, operative treatment.The medicine for the treatment of hyperosteogeny on market is existed everywhere, as: GUCIPING PIAN (Guangxi Qian Fang pharmaceutcal corporation, Ltd), spur and pain relieving liquid (Beijing Tongrentang Medical Wine Factory, Beijing Tongrentang Co Ltd) etc., really number is also countless, and all, to relieve the pain as principle for the treatment of, cure rate is low, can only take stopgap measures and can not effect a permanent cure, all can not fundamentally cure curing hyperosteogeny disease, oral, effect is undesirable, side effect is large, impairing the liver gallbladder taste etc.; The plaster of external, effect neither be fine, and skin is had to stimulation, has allergic phenomena, and fumigation and wash method transdermal deficiency, is difficult to full effect.Pin cutter, anesthesia needle therapy, its shortcoming is: pin cutter is to destroy diseased region, and anesthesia needle is to block local nerve conduction temporarily, only plays interim effect and is difficult to arrive the effect of curing.And operative treatment has a big risk, expense is high, patient suffering, and easily cause the disadvantage such as sequela or recurrence.
The patient who suffers from now bone matrix hyperplasia is more and more, how to find a kind of therapeutic effect significantly, the method for the treatment hyperosteogeny that has no side effect becomes the urgent needs of this area.And moxa-moxibustion is because its therapeutic effect is remarkable, the gentle favor that enjoys people of process.But up to the present, known moxibustion treatment energy temperature three-way meridian, QI and blood regulating, blood circulation promoting, but also there is no the moxa roll for bone matrix hyperplasia treatment specially.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of moxa roll for the treatment of hyperosteogeny, and with this moxa roll, by moxibustion treatment hyperosteogeny, effect is remarkable, have no side effect, and process gentleness.
For achieving the above object, the present invention takes following technical scheme:
Treat a moxa roll for hyperosteogeny, made by the raw material of following weight portion: 80~95 parts of Folium Artemisiae Argyis, 10~20 parts of Radix Clematidis, 10~15 parts of Herba Pyrolaes, 8~15 parts of Carapax et Plastrum Testudiniss, 8~12 parts, Semen Persicae, 5~10 parts of Rhizoma Cibotiis, 2~8 parts, Radix Rehmanniae Preparata, 2~7 parts of Radix Angelicae Sinensis, 1~5 part of Rhizoma Zingiberis.
The moxa roll for the treatment of hyperosteogeny of the present invention, preferably, is made up of the raw material of following weight portion: 85~90 parts of Folium Artemisiae Argyis, 13~18 parts of Radix Clematidis, 12~14 parts of Herba Pyrolaes, 10~12 parts of Carapax et Plastrum Testudiniss, 9~11 parts, Semen Persicae, 6~8 parts of Rhizoma Cibotiis, 4~6 parts, Radix Rehmanniae Preparata, 3~5 parts of Radix Angelicae Sinensis, 2~4 parts of Rhizoma Zingiberiss.
The moxa roll for the treatment of hyperosteogeny of the present invention, best, is made up of the raw material of following weight portion: 88 parts of Folium Artemisiae Argyis, 15 parts of Radix Clematidis, 13 parts of Herba Pyrolaes, 11 parts of Carapax et Plastrum Testudiniss, 10 parts, Semen Persicae, 7 parts of Rhizoma Cibotiis, 5 parts, Radix Rehmanniae Preparata, 4 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Zingiberiss.
Moxa roll length of the present invention is 21~25cm, and diameter is 2.9~3.2cm.Right power deficiency when less, the moxa-moxibustion of moxa roll diameter on the market at present, is difficult to reach thermal sensitive effect, thereby affects moxa-moxibustion effect.And moxa roll of the present invention combustion power abundance, while making skin reach certain temperature, can produce follow through thermal sensitive effect, when moxa-moxibustion, coordinate again medicine enter through, can greatly improve the effect for the treatment of hyperosteogeny.
Folium Artemisiae Argyi of the present invention be Folium Artemisiae Argyi through repeatedly shining pestle, beat, pulverizing, screen out impurity, dust, and the soft thin as cotton article that obtain are convenient to burning with Folium Artemisiae Argyi, improve combustion power.
In pharmaceutical composition of the present invention:
Folium Artemisiae Argyi, be by Folium Artemisiae Argyi through repeatedly shining pestle, beat, pulverizing, screen out impurity, dust, and the soft thin as cotton article that obtain.Nature and flavor: acrid in the mouth, hardship, warm in nature, nontoxic.Function cures mainly: have warming the meridian for stopping bleeding, dispersing cold for relieving pain, effect of wet down parasite killing; Cure mainly menoxenia, dysmenorrhea, infertility, frequent fetal movement, trusted subordinate's cold type of pain, spits blood, epistaxis, spitting of blood, has blood in stool, metrorrhagia, gestation hemorrhage, the chronic dysentery of having loose bowels, leukorrhagia, eczema, scabies, carbuncle, hemorrhoid, moxibustion treatment all kinds of diseases and ailments.
Radix Clematidis is the rhizome of ranunculaceae plant Radix Clematidis, Clematis hexapetala or northeast clematis etc.Nature and flavor: taste is micro-pungent salty.Function cures mainly: have expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, expectorant water, loose hypochondriac lump effect; Cure mainly gout insensitive impediment, rheumatic arthralgia, numb limbs and tense tendons, knee joint cold type of pain, the contracture of muscle arteries and veins, joint stuffiness, beriberi, malaria, lump in the abdomen, tetanus, tonsillitis, all a fishbone or other bone caught in the throat pharynxs.
Herba Pyrolae is the herb of Pyrolaceae plant Herba pyrolae japonicae or Pylora rotundolia etc.Nature and flavor: sweetness and bitterness, temperature.Function cures mainly: energy tonify deficiency, kidney tonifying, expelling wind and removing dampness, promoting blood flow to regulate menstruation, the kidney invigorating bone strengthening, cough-relieving, hemostasis; Cure mainly: main lumbago due to renal deficiency, rheumatic arthralgia, soft, the new chronic cough of muscles and bones flaccidity are coughed, haematemesis, epistaxis, metrorrhagia, traumatic hemorrhage.
Carapax et Plastrum Testudinis is sternite and the carapace of Testudinidae animal chinemys reevesii.Nature and flavor: salty sweet, flat.Function cures mainly: YIN nourishing, YANG hyperactivity suppressing, the kidney invigorating, strong bone; Cure mainly deficiency of kidney yin, hectic fever due to YIN-deficiency consumptive fever, spits blood, epistaxis, chronic cough, seminal emission, metrorrhagia, leukorrhagia, lumbago, the atrophic debility of bones, stirring of wind due to deficiency of YIN, chronic dysentery, chronic malaria, hemorrhoid, non-closure of fontanels jin infants.
Semen Persicae is the seed of rosaceous plant Fructus Persicae or Prunus davidiana.Nature and flavor: hardship, flat.Function cures mainly: the effect that has blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Can be used for amenorrhea, dysmenorrhea, WEIJIA mass in the abdomen, injury from falling down, dryness of the intestine constipation etc.
Rhizoma Cibotii is the rhizome of Dicksoniaceae plant Cibotium barometz (L.) J. Sm..Nature and flavor: bitter in the mouth, sweet, warm in nature.Function cures mainly: invigorating the liver and kidney, strengthening bone and muscle, wind-damp dispelling; Cure mainly deficiency of the liver and kindey, the acid of waist knee joint is cold, and lower limb is soft weak, and rheumatic arthralgia.Rhizoma Cibotii belongs to strong muscles and bones medicine, and the disease that muscles and bones is not good for has the dual function for the treatment of and health care.
Radix Rehmanniae Preparata is the tuber of scrophulariaceae rehmannia glutinosa plant (formal name used at school: Rehmannia glutinosa).Nature and flavor: sweet in the mouth; Warm in nature.Function cures mainly: enrich blood moist, beneficial essence is filled out marrow.Cure mainly blood tiger sallow, dizzy cardiopalmus, menoxenia, collapses incessantly, hepatic and renal YIN deficiency, hectic fever night sweat, seminal emission sexual impotence, infertility, soreness of the waist and knees, Hiccough and deaf, the head is dim-sighted, and early whitening of beard and hair is quenched one's thirst, constipation, the dyspnea with rapid and short breath of suffering from a deficiency of the kidney.
Radix Angelicae Sinensis is the root of herbaceos perennial.Nature and flavor: sweet in the mouth, pungent, hardship, warm in nature.Function cures mainly: enrich blood, invigorate blood circulation, menstruction regulating and pain relieving, moisturizes laxation.Cure mainly all cards of blood deficiency, menoxenia, amenorrhea, dysmenorrhea, lump in the abdomen knot is poly-, metrorrhagia, asthenia cold abdominalgia, flaccidity syndrome and arthralgia syndrome, numbness of the skin, dryness of the intestine dyschezia, heavy after bloody dysentery, ulcer sores, injury from falling down.
Rhizoma Zingiberis is the dry product of Rhizoma Zingiberis Recens.Nature and flavor: pungent, heat.Function cures mainly: for warm spleen sun, partially controls spleen-cold syndrome stomachache and has loose bowels, can promote blood circulation by recuperating depleted YANG again, and warming the lung to resolve fluid-retention, with controlling yang depletion syndrome, extremity are fainted contrary, faint pulse being about to disappear, and cold fluid-retention cough with asthma, the cold physique back of the body is cold, the clear rare disease of waiting of abundant expectoration.
The preparation method of moxa roll that the present invention treats hyperosteogeny is as follows:
The whole raw materials that dry are dried, and by other raw material mix homogeneously except Folium Artemisiae Argyi, Ultrasonic Pulverization becomes 20~50 order fine powders, again the fine drug powder of Folium Artemisiae Argyi and pulverizing being put into blender stirs, then mixture is added in banded extruder and push slivering, packaging, obtains moxa roll.
Compared with prior art, beneficial effect of the present invention is:
1, moxa roll of the present invention is for moxa-moxibustion, and active drug, without the intestines and stomach, is avoided medicine irritation the intestines and stomach, process gentleness.
2, the ratio on moxa roll of the present invention and market, diameter increases, and combustion power foot can make skin reach thermal sensitive effect in moxa-moxibustion process, accelerates the conduction of the efficacy of a drug, improves the effect for the treatment of hyperosteogeny.
3, moxa roll of the present invention is made by various raw materials, as Radix Clematidis, Semen Persicae blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, Herba Pyrolae, Carapax et Plastrum Testudinis and Rhizoma Cibotii the kidney invigorating bone strengthening, expelling wind and removing dampness, Radix Rehmanniae Preparata, Chinese angelica blood supplementing moisten, beneficial essence is filled out marrow, and Rhizoma Zingiberis can promote local telangiectasis, promotes the drug effect Transdermal absorption of each taste medicine, improve moxa roll drug effect of the present invention, each medicine is mutually collaborative, and treatment hyperosteogeny effect is remarkable, and effective percentage reaches more than 97.5%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described, but the present invention is not limited to these embodiment.
Embodiment 1
Treat a moxa roll for hyperosteogeny, made by the raw material of following weight portion: 80 parts of Folium Artemisiae Argyis, 10 parts of Radix Clematidis, 10 parts of Herba Pyrolaes, 8 parts of Carapax et Plastrum Testudiniss, 8 parts, Semen Persicae, 5 parts of Rhizoma Cibotiis, 2 parts, Radix Rehmanniae Preparata, 2 parts of Radix Angelicae Sinensis, 1 part of Rhizoma Zingiberis.
The preparation of moxa roll: the whole raw materials that dry are dried, by other raw material mix homogeneously except Folium Artemisiae Argyi, Ultrasonic Pulverization becomes 20 order fine powders, again the fine drug powder of Folium Artemisiae Argyi and pulverizing being put into blender stirs, then mixture is added in banded extruder and push slivering, its length is 21cm, and diameter is 2.9cm, packaging, obtains moxa roll.
Embodiment 2
Treat a moxa roll for hyperosteogeny, made by the raw material of following weight portion: 85 parts of Folium Artemisiae Argyis, 13 parts of Radix Clematidis, 12 parts of Herba Pyrolaes, 10 parts of Carapax et Plastrum Testudiniss, 9 parts, Semen Persicae, 6 parts of Rhizoma Cibotiis, 4 parts, Radix Rehmanniae Preparata, 3 parts of Radix Angelicae Sinensis, 2 parts of Rhizoma Zingiberiss.
The preparation of moxa roll: the whole raw materials that dry are dried, by other raw material mix homogeneously except Folium Artemisiae Argyi, Ultrasonic Pulverization becomes 30 order fine powders, again the fine drug powder of Folium Artemisiae Argyi and pulverizing being put into blender stirs, then mixture is added in banded extruder and push slivering, its length is 22cm, and diameter is 3.0cm, packaging, obtains moxa roll.
Embodiment 3
Treat a moxa roll for hyperosteogeny, made by the raw material of following weight portion: 88 parts of Folium Artemisiae Argyis, 15 parts of Radix Clematidis, 13 parts of Herba Pyrolaes, 11 parts of Carapax et Plastrum Testudiniss, 10 parts, Semen Persicae, 7 parts of Rhizoma Cibotiis, 5 parts, Radix Rehmanniae Preparata, 4 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Zingiberiss.
The preparation of moxa roll: the whole raw materials that dry are dried, by other raw material mix homogeneously except Folium Artemisiae Argyi, Ultrasonic Pulverization becomes 40 order fine powders, again the fine drug powder of Folium Artemisiae Argyi and pulverizing being put into blender stirs, then mixture is added in banded extruder and push slivering, its length is 23cm, and diameter is 3.1cm, packaging, obtains moxa roll.
Embodiment 4
Treat a moxa roll for hyperosteogeny, made by the raw material of following weight portion: 90 parts of Folium Artemisiae Argyis, 18 parts of Radix Clematidis, 14 parts of Herba Pyrolaes, 12 parts of Carapax et Plastrum Testudiniss, 11 parts, Semen Persicae, 8 parts of Rhizoma Cibotiis, 6 parts, Radix Rehmanniae Preparata, 5 parts of Radix Angelicae Sinensis, 4 parts of Rhizoma Zingiberiss.
The preparation of moxa roll: the whole raw materials that dry are dried, by other raw material mix homogeneously except Folium Artemisiae Argyi, Ultrasonic Pulverization becomes 40 order fine powders, again the fine drug powder of Folium Artemisiae Argyi and pulverizing being put into blender stirs, then mixture is added in banded extruder and push slivering, its length is 24cm, and diameter is 3.2cm, packaging, obtains moxa roll.
Embodiment 5
Treat a moxa roll for hyperosteogeny, made by the raw material of following weight portion: 95 parts of Folium Artemisiae Argyis, 20 parts of Radix Clematidis, 15 parts of Herba Pyrolaes, 15 parts of Carapax et Plastrum Testudiniss, 12 parts, Semen Persicae, 10 parts of Rhizoma Cibotiis, 8 parts, Radix Rehmanniae Preparata, 7 parts of Radix Angelicae Sinensis, 5 parts of Rhizoma Zingiberiss.
The preparation of moxa roll: the whole raw materials that dry are dried, by other raw material mix homogeneously except Folium Artemisiae Argyi, Ultrasonic Pulverization becomes 50 order fine powders, again the fine drug powder of Folium Artemisiae Argyi and pulverizing being put into blender stirs, then mixture is added in banded extruder and push slivering, its length is 25cm, and diameter is 3.0cm, packaging, obtains moxa roll.
Test example: the clinical efficacy of the moxa roll for the treatment of hyperosteogeny of the present invention
The moxa roll of 1, medicine: embodiment, 1~5 preparation.
2, case: select 396 routine clinical cases, wherein hyperosteogeny, spinal canal stenosis, 98 examples, male 46 examples, female's 52 examples; Hyperosteogeny, spinal canal stenosis, 131 examples, wherein male 61 examples, female's 70 examples; Knee joint, elbow or ankle joint hypertrophy 167 examples, male 64 examples, female's 103 examples.
3, diagnostic criteria:
Clinical manifestation:
(1) hyperosteogeny and spinal canal stenosis, clinical manifestation is: dizzy dizzy, distending pain, eye is puckery swollenly feels bad, point numb, have click feel, shoulder and brachialgia, feel sick or dysuria with uncomfortable in chest individually, serious symptom is amyotrophy, limb adynamia compressing lower limb, and foot is stepped on cotton shape, had click feel etc.
(2) hyperosteogeny, spinal canal stenosis, waist is ached not obvious, but compressing ischium place pain shape is obvious, inner side pain after the fiber crops of lateral side of femur numbness, shank outside, some knee-joint pain, human hair combing waste fiber crops, have click feel or cool pain, limb adynamia, have individually amyotrophy, Cotton Gossypii sense is stepped in walking, can not straight line moving etc.
(3) knee joint, ankle or elbow joint hypertrophy, mainly with the limited difficulty in walking of bending, fortune oxycinesia shape is obvious, if knee hyperplasia severe one walking lower limb is tetanic, resting state pain is light or asymptomatic, and what have causes synovitis, tibia osteodynia, joint space narrow (joint deformity) etc.
4, treatment standard:
Above-mentioned symptom disappears for curing, after 1 year, X-ray shows, the sharp sour jujube of hypertrophy becomes convex, existing degeneration, thereby the cartilage to joint, ligament and canalis spinalis produce friction and irritate transference cure without sharp sour jujube because of hypertrophy position, thereby reach other transference cures of pain shape or compressing.Not all hypertrophy part all disappears, but hypertrophy position degenerates to the calcification layer of skeletonization, but or else growth, thereby reach healing object.
5, Therapeutic Method:
With moxa roll of the present invention to disease sites moxa-moxibustion, the each 20min in each position, each 2~3 times, a month course for the treatment of, patients with mild heals 1 course for the treatment of, serious symptom need add 1~2 course for the treatment of.
6, therapeutic outcome:
In the patient of 396 examples except female patient's diseased region of 3 hyperosteogenys with calcification, all cure effective percentage 96.9%; Hyperosteogeny patient has 3 DeGrains, and wherein 2 calcifications by name, another 1 are called and made pin cutter, and all the other are all cured, effective percentage 97.7%; Knee joint has 1 not heal, and repeatedly makes anesthesia needle because of it, and all the other are all healed, effective percentage 99.4%; Total effective rate 97.5%.

Claims (5)

1. a moxa roll for the treatment of hyperosteogeny, is characterized in that, is made up of the raw material of following weight portion: 80~95 parts of Folium Artemisiae Argyis, 10~20 parts of Radix Clematidis, 10~15 parts of Herba Pyrolaes, 8~15 parts of Carapax et Plastrum Testudiniss, 8~12 parts, Semen Persicae, 5~10 parts of Rhizoma Cibotiis, 2~8 parts, Radix Rehmanniae Preparata, 2~7 parts of Radix Angelicae Sinensis, 1~5 part of Rhizoma Zingiberis.
2. the moxa roll for the treatment of hyperosteogeny according to claim 1, it is characterized in that, raw material by following weight portion is made: 85~90 parts of Folium Artemisiae Argyis, 13~18 parts of Radix Clematidis, 12~14 parts of Herba Pyrolaes, 10~12 parts of Carapax et Plastrum Testudiniss, 9~11 parts, Semen Persicae, 6~8 parts of Rhizoma Cibotiis, 4~6 parts, Radix Rehmanniae Preparata, 3~5 parts of Radix Angelicae Sinensis, 2~4 parts of Rhizoma Zingiberiss.
3. the moxa roll for the treatment of hyperosteogeny according to claim 1 and 2, is characterized in that, is made up of the raw material of following weight portion: 88 parts of Folium Artemisiae Argyis, 15 parts of Radix Clematidis, 13 parts of Herba Pyrolaes, 11 parts of Carapax et Plastrum Testudiniss, 10 parts, Semen Persicae, 7 parts of Rhizoma Cibotiis, 5 parts, Radix Rehmanniae Preparata, 4 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Zingiberiss.
4. according to the moxa roll of the treatment hyperosteogeny described in claim 3 any one, it is characterized in that: described Folium Artemisiae Argyi be Folium Artemisiae Argyi through repeatedly shining pestle, beat, pulverizing, screen out impurity, dust, and the soft thin as cotton article that obtain.
5. according to the moxa roll of the treatment hyperosteogeny described in claim 3 any one, it is characterized in that: described moxa roll length is 21~25cm, diameter is 2.9~3.2cm.
CN201410437261.XA 2014-08-29 2014-08-29 A kind of moxa stick for treating osteoproliferation Active CN104147580B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410437261.XA CN104147580B (en) 2014-08-29 2014-08-29 A kind of moxa stick for treating osteoproliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410437261.XA CN104147580B (en) 2014-08-29 2014-08-29 A kind of moxa stick for treating osteoproliferation

Publications (2)

Publication Number Publication Date
CN104147580A true CN104147580A (en) 2014-11-19
CN104147580B CN104147580B (en) 2017-10-24

Family

ID=51873343

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410437261.XA Active CN104147580B (en) 2014-08-29 2014-08-29 A kind of moxa stick for treating osteoproliferation

Country Status (1)

Country Link
CN (1) CN104147580B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343149A (en) * 2015-12-02 2016-02-24 山东中医药大学 Application of eucommia ulmoides to preparation of medicinal moxa sticks
CN112076293A (en) * 2019-06-12 2020-12-15 馆陶县中医医院 Preparation method of moxa stick for improving physique

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1150910A (en) * 1996-04-18 1997-06-04 花茂时 Osteophytosis pill and its compounding method
CN102188491A (en) * 2011-05-01 2011-09-21 仲慧卿 Formula of acupuncture tool for thunder fire needle and manufacturing method
CN102451461A (en) * 2010-10-27 2012-05-16 贺琴 Traditional Chinese medicine (TCM) for treating hyperosteogeny
CN103099890A (en) * 2013-02-28 2013-05-15 赵文慧 Formula of traditional Chinese medicine moxibustion
CN103690905A (en) * 2012-09-27 2014-04-02 李桂林 Moxibustion medicinal strip for treating rheumatic arthralgia

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1150910A (en) * 1996-04-18 1997-06-04 花茂时 Osteophytosis pill and its compounding method
CN102451461A (en) * 2010-10-27 2012-05-16 贺琴 Traditional Chinese medicine (TCM) for treating hyperosteogeny
CN102188491A (en) * 2011-05-01 2011-09-21 仲慧卿 Formula of acupuncture tool for thunder fire needle and manufacturing method
CN103690905A (en) * 2012-09-27 2014-04-02 李桂林 Moxibustion medicinal strip for treating rheumatic arthralgia
CN103099890A (en) * 2013-02-28 2013-05-15 赵文慧 Formula of traditional Chinese medicine moxibustion

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘桂廷等: "壮骨柔筋法治疗骨质增生60例", 《实用中医内科杂志》 *
王卫生、王琴琢: "《骨质增生症》", 30 September 2000 *
王民集等: "《中国针灸全书》", 30 June 2012 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343149A (en) * 2015-12-02 2016-02-24 山东中医药大学 Application of eucommia ulmoides to preparation of medicinal moxa sticks
CN112076293A (en) * 2019-06-12 2020-12-15 馆陶县中医医院 Preparation method of moxa stick for improving physique

Also Published As

Publication number Publication date
CN104147580B (en) 2017-10-24

Similar Documents

Publication Publication Date Title
CN101229357B (en) Chinese traditional medicine for treating mammary glands hyperplasia
CN103191377A (en) Plaster for treating rheumatoid bone diseases
CN104189871A (en) Medicated wine for treating osteoproliferation
CN104353019A (en) Traditional Chinese medicine hot compress bag with meridian dredging and internal organ conditioning functions and preparation method of traditional Chinese medicine hot compress bag
CN102908414B (en) External use plaster for treating fracture and traumatic injury
CN102698085B (en) Chinese medicinal plaster for treating arthritis
CN102772600B (en) Externally used medicine for treating osseous rheumatism
CN104147580B (en) A kind of moxa stick for treating osteoproliferation
CN101703619A (en) Chinese medicament for treating hyperosteogeny and osteoarthritis
CN107412491A (en) A kind of externally applied ointment for treating hyperosteogeny patch and preparation method thereof
CN103340972B (en) Traditional Chinese medicine composition for treating traumatic injuries
CN106177098A (en) A kind of pill medicine treating soreness of waist and knee joint and preparation method thereof
CN102416049B (en) Small square type rheumatoid swelling diminishing and pain eliminating plaster and preparation method thereof
CN105412581A (en) Traditional Chinese medicine preparation for treating stenosing tendovaginitis radial styloid and preparation method
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN104606661A (en) Traditional Chinese medicinal galactagogue for treating hypogalactia after cesarean delivery and preparation method of galactagogue
CN102784329A (en) External fumigation-washing traditional Chinese medicine for treating sports injury and tumescent osteoarthrosis
CN104027451B (en) A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica
CN102008648A (en) External washing traditional Chinese medicine for treating femoral head necrosis
CN106421255A (en) Topical traditional Chinese composition and its application
CN106389991A (en) Navel treatment drug composition for andrology diseases as well as preparation method and application of navel treatment drug composition
CN105853782A (en) Traditional Chinese medicinal composition for treating uterine prolapsed
CN105641187A (en) Far-infrared therapeutic plaster
CN104645242A (en) Plaster for treating rheumatic bone diseases
CN103599441A (en) Externally-applied traditional Chinese medicine ointment for treating traumatic injury, catagma, old rheumatalgia and trauma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20191203

Address after: 541001 No.135, weishijia village, Silian village, Dahe Township, Diecai District, Guilin City, Guangxi Zhuang Autonomous Region

Patentee after: Guilin baoguhong AI Pharmaceutical Technology Co., Ltd

Address before: 541002 No. three, Lane 24-1, Chongxin Road, Guilin, the Guangxi Zhuang Autonomous Region

Patentee before: GUILIN AIKANG TECHNOLOGY CO., LTD.